Boston Scientific (NYSE:BSX) must pay $42 million in unpaid royalties to TissueGen and the University of Texas, a federal jury in Delaware has ruled. The jury verdict yesterday came after the finding that Boston Scientific’s Synergy BP drug-eluting stents infringed on TissueGen and the university’s IP. The patent under question arose out of research that […]
TissueGen
Tackling drug delivery challenges with TissueGen’s implantable fibers
TissueGen‘s chief scientist and co-founder, Kevin Nelson, told Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber. DDBN: How did TissueGen get its start? Nelson: In 1996, while faculty in biomedical engineering at The University of Texas at Arlington, I was working with […]
11 companies with interesting technology at MD&M East
Thousands of engineers and executives are expected to descend on the Javits Center in New York next week for MD&M East, the largest medical device manufacturing event on the East Coast. Fun attractions include Apple co-founder Steve “Woz” Wozniak delivering a keynote speech, the 19th annual Medical Design Excellence Awards, robot battles and a 3D printed […]
